The Dharmanol product line as credible challengers

The Dharmanol product line as credible challengers to Big Pharma psychiatrics (most prescribed of all drugs) may be the biggest SKTO story not yet told except in small venues. In the same context is its potential application to replace Ritalin and other problematic compounds pharma touts for Attention Deficit Hyperactivity Disorder (ADHD) which is near epidemic proportions. Nearly all of the teenage school shooters were being given these drugs. Mayo Clinic says 7.5m US children of school age are affected with ADHD.